Herbalife Ltd

The stock is in a Stage 4 decline under confirmed lower-highs and lower-lows with price trading below all key EMAs, and an active Support Failure pattern signals persistent selling pressure. Short-term momentum remains negative with price consistently below EMAs and no exhaustion signals, so bearish execution should be initiated immediately via a Sell Now.

• ↑Q1 2026 net sales $1.3 B (+7.8% YoY), strongest growth since Q2 2021.
• ↑Bionic acquisition accelerates personalized vitamin/mineral portfolio rollout.
• ↓Full-year 2024 sales seen down 1.5%, signaling revenue stagnation.